SCHEMBL23713490

SCHEMBL23713490

C=CC(=O)OC(C)(C)c1ccc2cc(-c3ccccc3C(F)(F)F)c(=O)oc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 3/20 0.40
KDM4E B2RXH2 5/20 0.38
HPGD P15428 4/20 0.38
NPC1 O15118 7/20 0.38
RAB9A P51151 6/20 0.38
KMT2A Q03164 3/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 1/20 0.38
GLA P06280 3/20 0.37
GAA P10253 3/20 0.35
MGAM O43451 1/20 0.35
SI P14410 1/20 0.35
MGAM2 Q2M2H8 1/20 0.35
TERT O14746 3/20 0.35
CYP19A1 P11511 1/20 0.34
MAOB P27338 2/20 0.34
KLK7 P49862 1/20 0.34
S1PR4 O95977 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24046232 0.81 MIF (0.36) MIFKDM4EHPGDNPC1RAB9A
SCHEMBL26854645 0.80 KLK7 (0.42) MIFKDM4EHPGDNPC1RAB9A
SCHEMBL21116161 0.80 NPC1 (0.39) MIFKDM4EHPGDNPC1RAB9A
SCHEMBL24046288 0.79 MIF (0.38) MIFKDM4EHPGDNPC1RAB9A
SCHEMBL18535561 0.78 KDM4E (0.46) KDM4EHPGDNPC1RAB9AKMT2A
SCHEMBL18535493 0.74 GLA (0.67) KDM4EHPGDNPC1RAB9AKMT2A
SCHEMBL18535489 0.74 MIF (0.65) MIFKDM4EHPGDNPC1RAB9A
SCHEMBL21524281 0.74 MAOB (0.51) MIFCYP19A1MAOB
SCHEMBL18535568 0.73 RAB9A (0.40) MIFKDM4EHPGDNPC1RAB9A
SCHEMBL27105690 0.73 KLK7 (0.41) MIFKDM4EHPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A MIF 1378/4885KDM4E 4039/4885HPGD 387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.